Recent reports propose IL-17A as an important mediator in non-renal fibrosis, bleomycin induced pulmonary fibrosis [37], [38] and hepatic fibrosis induced by either cholestasis or hepatotoxic agents [39]. This evidence concerns the gene IL17A and cholestasis.